Dr. Steven M Culp, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 W Meeting St, Suite 200, Lancaster, SC 29720 Phone: 803-285-7414 Fax: 803-283-4329 |
Sharon T Browning, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 838 W Meeting St, Building 5, Suite H, Lancaster, SC 29720 Phone: 803-285-2273 Fax: 803-283-6360 |
Mrs. Cassie Callahan Jenkins, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 1025 W Meeting St, Lancaster, SC 29720 Phone: 803-285-7414 |
Mr. Amrendra Kumar, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1130 Hwy 9 Bypass W, Lancaster, SC 29720 Phone: 803-285-2225 |
Roy A Still, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1228 Colonial Commons Ct, Lancaster, SC 29720 Phone: 803-283-2011 Fax: 803-286-9962 |
Dr. Keith D Shealy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 W Meeting St, Suite 200, Lancaster, SC 29720 Phone: 803-285-7414 Fax: 803-283-4329 |
Dr. Linda C Daily, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1025 W Meeting St, Suite 200, Lancaster, SC 29720 Phone: 803-285-7414 Fax: 803-283-4329 |
Dr. Kristin Shannon Black, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 820 W Meeting St, Lancaster, SC 29720 Phone: 803-285-5441 |
Jaime Christine Wise, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 800 W Meeting St, Lancaster, SC 29720 Phone: 803-286-1214 Fax: 888-507-9833 |
Dr. Frank Sharp, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 W Meeting St, Suite 200, Lancaster, SC 29720 Phone: 803-285-7414 Fax: 803-283-4329 |
Dr. Paul A. Lingoes, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1201 Colonial Commons, Agape Physicians Care, Lancaster, SC 29720 Phone: 803-207-8200 Fax: 803-207-8130 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.
Two years of maintenance therapy with rituximab dramatically improves the chances of survival for patients suffering from one of the most frequent forms of lymphoma, indolent non-Hodgkin's Lymphoma (NHL).
The newly retired Chief Executive Officer of Roche Pharmaceuticals Bill Burns today led calls for more public-private partnerships in the pharmaceutical industry at the launch of the Italian Institute of Technology's Drug Discovery and Development Unit (D3).
Scientists involved in the EU-funded project ChildInnovac are about to publish in the online journal Plos One the results of their first clinical trial of a new nasal vaccine.
› Verified 2 days ago